Identification of FDA-approved anti-cancer drugs that could be repurposed toward CNS diseases Contributor Scientific Reports Behind the paper Identification of FDA-approved anti-cancer drugs that could be repurposed toward CNS diseases Paul Wadsworth Nov 19, 2019
